Wellgistics Health, Inc.
WGRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.03 | -0.00 | 1.05 |
| FCF Yield | -1.11% | -3.70% | -0.72% | -1.40% |
| EV / EBITDA | -2.86 | -17.99 | -8.11 | 336.75 |
| Quality | ||||
| ROIC | -95.67% | -21.34% | -103.73% | 1.67% |
| Gross Margin | 7.67% | 6.49% | 6.38% | 7.46% |
| Cash Conversion Ratio | 0.03 | 0.31 | 0.04 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,777,713.88% | 2,640,265.82% | 2,761,163.38% | 2,626,878.99% |
| Free Cash Flow Growth | 66.97% | -36.43% | 41.54% | -350.06% |
| Safety | ||||
| Net Debt / EBITDA | -0.71 | -5.22 | -0.76 | 36.53 |
| Interest Coverage | -22.13 | -4.65 | -28.64 | -1.55 |
| Efficiency | ||||
| Inventory Turnover | 0.37 | 0.81 | 1.04 | -1.56 |
| Cash Conversion Cycle | -61.59 | 40.63 | 46.33 | -40.31 |